CD47 and myelodysplastic syndrome: These phenotypic populations can display additional surface markers which differentially mark MDS HSPCs for a higher risk such as CD47, interleukin-1-receptor accessory protein (IL1RAP), CD99, CD123, and TIM3 (5).